Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries

Treatment outcomes of the shorter regimen for rifampicin-resistant tuberculosis are not completely established. We report on these outcomes two years after treatment completion among patients enrolled in an observational cohort study in nine African countries. 1,006 patients treated with the nine-mo...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	EClinicalMedicine Ročník 20; s. 100268
Hlavní autoři:	Schwœbel, Valérie, Trébucq, Arnaud, Kashongwe, Zacharie, Bakayoko, Alimata S., Kuaban, Christopher, Noeske, Juergen, Harouna, Souleymane H., Souleymane, Mahamadou B., Piubello, Alberto, Ciza, François, Fikouma, Valentin, Gasana, Michel, Ouedraogo, Martial, Gninafon, Martin, Van Deun, Armand, Tagliani, Elisa, Cirillo, Daniela M., Koura, Kobto G., Rieder, Hans L.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Elsevier Ltd 01.03.2020 Elsevier
Témata:	Cohort studies Developing countries Fluoroquinolones Internal Medicine Isoniazid Multidrug-resistance Proportional hazard models Recurrence Research paper Short regimen Treatment outcome Tuberculosis Fluoroquinolones Treatment outcome Recurrence Tuberculosis Short regimen Cohort studies Developing countries Proportional hazard models Isoniazid Multidrug-resistance
ISSN:	2589-5370, 2589-5370
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!